Cargando…
Implications of Concurrent IDH1 and IDH2 Mutations on Survival in Glioma—A Case Report and Systematic Review
Both IDH1 (isocitrate dehydrogenase 1) and IDH2 (isocitrate dehydrogenase 2) mutations play a vital role in the development of gliomas through disruption of normal cellular metabolic processes. Here we describe a case of a patient with an IDH-mutant astrocytoma, in which both IDH1 and IDH2 mutations...
Autores principales: | Yuile, Alexander, Satgunaseelan, Laveniya, Wei, Joe, Kastelan, Marina, Back, Michael F., Lee, Maggie, Wei, Heng, Buckland, Michael E., Lee, Adrian, Wheeler, Helen R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600580/ https://www.ncbi.nlm.nih.gov/pubmed/36286062 http://dx.doi.org/10.3390/cimb44100348 |
Ejemplares similares
-
CDKN2A/B Homozygous Deletions in Astrocytomas: A Literature Review
por: Yuile, Alexander, et al.
Publicado: (2023) -
Promoter Methylation Analysis of IDH Genes in Human Gliomas
por: Flanagan, Simon, et al.
Publicado: (2012) -
Large tumour volume reduction of IDH-mutated anaplastic glioma involving the insular region following radiotherapy
por: Metz, Gabrielle, et al.
Publicado: (2022) -
Targeting IDH1 and IDH2 Mutations in Acute Myeloid Leukemia: Emerging Options and Pending Questions
por: Wouters, Bas J.
Publicado: (2021) -
Concurrent inhibition of IDH and methyltransferase maximizes therapeutic efficacy in IDH mutant acute myeloid leukemia
por: Zeng, Zhihong, et al.
Publicado: (2021)